Radioactive iodine therapy for thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial studies whether giving more radioactive iodine (RAI) can help adults with differentiated thyroid cancer (a type of thyroid cancer) who still have signs of disease in their blood after initial treatment. It is for people who had their thyroid removed and have already had RAI therapy but show persistent or returning biochemical disease (abnormal blood markers) without any visible tumors on scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of differentiated thyroid cancer (a common type of thyroid cancer that responds to RAI).
- You must have had your entire thyroid gland removed (total thyroidectomy).
- You must have already received radioactive iodine therapy in the past.
- You must have signs of persistent or recurrent disease based on blood tests (like elevated thyroglobulin), but no visible tumors on imaging.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain cancer “targeted therapy” medicines can make radioactive iodine (RAI) therapy work better for thyroid cancer that has spread to the lungs. It also involves taking special whole-body scans to measure how much radioactive iodine gets taken up by the cancer.
This study looks at how well thyroid hormone replacement works after radioactive iodine treatment for high-risk thyroid cancer. It may help find the best way to manage your hormone levels after treatment.
This study looks at how much iodine your body absorbs after you follow a low-iodine diet before radioactive iodine treatment (131I) for thyroid cancer. It may help improve how safely and effectively this treatment is planned.
This study looks at how well radioactive iodine therapy works for patients with certain types of thyroid cancer that are considered low or intermediate risk. It may help you understand if this treatment is right for you.
This study looks at how different doses of radioactive iodine work for people with papillary or follicular thyroid cancer after their thyroid has been removed. It aims to find the best dose to treat the cancer while reducing side effects.
This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.
Hear when a new Differentiated Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.